comparemela.com

Latest Breaking News On - Antios therapeutics - Page 7 : comparemela.com

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABUS) - The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABUS) - The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Chutes & Ladders—Zimmer Biomet calls on Medtronic vet Jamali to lead spinout

Samir Mody as chief commercial officer, while  Friedrich Asmus signs on as SVP, clinical development and medical affairs. Meanwhile, the company has also tapped  Joel Centeno as SVP, manufacturing, quality and supply chain. Mody comes over from Medtronic, where he was vice president, CRHF strategy, health economics and reimbursement. Asmus previously served as VP of clinical development at ophthalmology biotech ProQR Therapeutics, while Centeno comes over after stints at Boston Scientific, Hologic and AltheaDx. > Antios Therapeutics has tapped  Tamra Adams as chief financial officer, a newly created executive position at the company. Before joining Antios, Adams founded Accounting Concepts, which provided CFO, accounting, and financial services to emerging growth companies in the biopharmaceutical and information technology industries, including Engage Therapeutics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.